Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cook Medical EMR Gel, commercially known as LiftUp, is an FDA-approved submucosal injection agent used during endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD). It is designed to be injected into the submucosal layer of the gastrointestinal tract to create a high-viscosity, long-lasting cushion that elevates the target lesion (such as a polyp or early-stage tumor) away from the underlying muscularis propria. This "lift" provides a clear margin for resection, reduces the risk of thermal injury to the deeper wall layers during cautery, and minimizes the chance of perforation. The gel's viscosity is a critical factor in maintaining the height and duration of the lift, which was the focus of the ex-vivo study led by Antonios Likourezos (NCT02519140).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cook Medical EMR Gel.